Xeris Biopharma Holdings, Inc. (XERS)

Xeris Biopharma Holdings Revenue

Xeris Biopharma Holdings had revenue of $171.36M in the twelve months ending March 31, 2024, with 41.18% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $40.64M with 22.42% year-over-year growth. In the year 2023, Xeris Biopharma Holdings had annual revenue of $163.91M with 48.68% growth.

• Revenue (ttm): $171.36M
• Revenue Growth: +41.18%
• P/S Ratio: 1.78
• Revenue / Employee: $454,525
• Employees: 377
• Market Cap: 305.41M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	163.91M	53.67M	48.68%
Dec 31, 2022	110.25M	60.66M	122.32%
Dec 31, 2021	49.59M	29.16M	142.67%
Dec 31, 2020	20.44M	17.71M	650.73%
Dec 31, 2019	2.72M	299.00K	12.34%
Dec 31, 2018	2.42M	867.00K	55.72%
Dec 31, 2017	1.56M	481.00K	44.74%
Dec 31, 2016	1.08M	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.